Home > Insider Trading > Filing (0001567619-20-015709)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874716	Idexx Laboratories Inc	IDXX	In Vitro & In Vivo Diagnostic Substances (2835)	010393723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1403694	L. Bruce Claflin	C/O Idexx Laboratories, Inc. One Idexx Drive Westbrook ME 04092		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-08-14	1,111	$378.08	304	No	4	S	Direct
Common Stock	Acquisiton	2020-08-17	5,629	$70.54	5,933	No	4	M	Direct
Common Stock	Disposition	2020-08-18	5,629	$385.11	304	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right-to-buy)	Disposition	2020-08-17	5,629	$0.00	5,629	$70.54

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2025-08-31	No	4	M	Direct

Footnotes

Represents the weighted average price of the shares sold ranging from a low of $384.90 to a high of $385.765 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the date of the 2016 annual meeting of shareholders.
Not applicable.